Ranibizumab versus Bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN Randomized Trial

Usha Chakravarthy, Simon P. Harding, Chris A. Rogers, Susan M. Downes, Andrew J. Lotery, Sarah Wordsworth, Barnaby C Reeves,

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Ranibizumab versus Bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN Randomized Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences